Why Biden's strategy to prepare U.S. for future pandemics is 'underwhelming'


Earlier this month, the White House unveiled a new strategy aimed at preparing for future pandemics. The plan costs $65 billion over the next 10 years, and allocates a significant portion of those funds to developing technology that can quickly produce vaccines, antiviral drugs, and diagnostic tests.
It sounds like a promising start, but some experts aren't all that excited about it. "It's underwhelming," Mike Osterholm, an epidemiologist at the University of Minnesota, told The Atlantic's Ed Yong. "That $65 billion should have been a down payment, not the entire program. It's a rounding error for our federal budget, and yet our entire existence going forward depends on this."
Meanwhile, Alexandra Phelan, an expert on international law and global health policy at Georgetown University, told Yong that it's the way the funds are distributed that's concerning. "We're so focused on these high-tech solutions because they appear to be what a high-income country would do," she said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Instead, Yong writes, there's a case to be made that turning America's public health sector into a much more robust operation is just as essential as gearing up to produce vaccines. That means giving communities more money to hire and train more workers and improve their workplace infrastructure; it's not enough to simply react to emergencies in the future. Finally, there likely needs to be a greater effort to address the issues that make certain communities more vulnerable to public health crises than others — that could include increased paid sick leave, safe public housing, and food assistance, Yong writes.
For what it's worth, Eric Lander, the director of the Office of Science and Technology Policy and Biden's science adviser, agrees that the $65 billion plan isn't enough. "Nobody should read that plan as the limit of what needs to be done," he told Yong. "I have no disagreement that a major effort and very substantial funding are needed." Read more at The Atlantic.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
A tall ship adventure in the Mediterranean
The Week Recommends Sailing aboard this schooner and exploring Portugal, Spain and Monaco is a 'magical' experience
-
How drone warfare works
The Explainer From Ukraine to Iran, it has become clear that unmanned aircraft are rapidly revolutionising modern warfare
-
The tourist flood in the Mediterranean: can it be stemmed?
Talking Point Finger-pointing at Airbnb or hotel owners obscures the root cause of overtourism in holiday hotspots: unmanageable demand
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
Children's breakfast cereals are getting more unhealthy
Under the radar Your kids may be starting their day with more than a spoonful of sugar
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
A tick-borne illness is making its rounds in new parts of America
Under the radar Babesiosis, spread through blacklegged or deer tick bites, is a growing risk
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts